Estrogen Alone or in Combination with Parathyroid Hormone Can Decrease Vertebral MEF2 and Sclerostin Expression and Increase Vertebral Bone Mass in Ovariectomized Rats

H. B. Jia,J. X. Ma,X. L. Ma,J. T. Yu,R. Feng,L. Y. Xu,J. Wang,D. Xing,S. W. Zhu,Y. Wang
DOI: https://doi.org/10.1007/s00198-014-2818-y
2014-01-01
Osteoporosis International
Abstract:The study is about the regulatory effects of estrogen and parathyroid hormone (PTH) on sclerostin, a protein that inhibits the Wnt/β-catenin pathway. The results indicate that estrogen may down-regulate sclerostin expression and that estrogen displays synergistic action with PTH. These results provide a new perspective on the relationship between estrogen and bone.
What problem does this paper attempt to address?